Effect of cinnamon supplementation on blood glucose and lipid levels in type2 diabetic patients by خادم حقیقیان, حسین et al.
   Journal of Paramedical Sciences (JPS)                Winter 2011 Vol.2, No.1 ISSN 2008-4978 
_____________________________________________________________________________________________________________________________________________________________________________________                  
 
2 
Effect of cinnamon supplementation on blood glucose and lipid levels in 
type2 diabetic patients 
 
Hossein Khadem Haghighian
1
, Alireza Farsad Naimi 1, Bahram Pourghassem Gargari1, 
Akbar Ali-Asgharzadeh 
2
,
 
Ali Nemati
3 
 
1 Faculty of Health and Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran  
2Internal group of endocrinology, Tabriz University of Medical Sciences, Tabriz, Iran 
3 Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran 
 
*Corresponding Author: email address: a.nemati@arums.ac.ir (A. Nemati) 
 
ABSTRACT 
 
   This study was planned to investigate the effects of supplementation of cinnamon on fasting blood 
glucose levels and lipid profiles among type2 diabetic patients. 60 subjects with type 2 diabetes from 
both sexes (30 males and 30 females) were allocated to the intervention and control groups (30 
individuals per group). The doses of 1.5 g of cinnamon were equally administered orally in the form 
of cinnamon powder into 500 mg per capsule with breakfast, lunch, and dinner for 60 days. Control 
group received capsules of containing placebo. Blood samples were obtained on the beginning day of 
the experiment and at the end of 60 days. The fasting blood glucose levels and lipid profiles including 
total cholesterol, LDL-C, HDL-C and triglycerides of types 2 subjects were measured. Fasting blood 
glucose levels and lipid profiles in intervention group were significantly lower than control group 
(p<0.05). The average of fasting blood glucose levels, total cholesterol, cholesterol LDL and 
triglyceride levels were decreased after consumption of cinnamon powder, significantly(p<0.05). We 
observed no significant changes in fasting blood glucose levels and lipid profiles after consumption of 
placebo in control group. Conclusion: This study showed that consumption of cinnamon 
supplementation may be useful in control and decreasing of fasting blood glucose levels and lipid 
profiles among type 2 diabetes individuals. 
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INTRODUCTION  
     Diabetes is the most common endocrine 
disease and it is still a serious health problem 
all over the world. Approximately 3 million 
individuals suffer from diabetes in Iran.  The 
prevalence of diabetes in Iran is similar to 
some other developed countries (Alberti et al., 
1998). The cause of type 2 diabetes is 
multifactor.  Diet can play a major role in the 
incidence and progression of the disease 
(Carter et al., 1996). Drug treatment and 
dietary interventions are known to be effective 
tools to prevent type 2 diabetes (Willett et al., 
2002: Jenkins et al., 2002). Disorder of 
glucose metabolism resulting from 
dysfunction of pancreatic beta cells and 
insulin resistance is seen in diabetes mellitus. 
Medicinal herbs are expected to have a similar 
degree of efficacy without the troublesome 
side effects associated with conventional drug 
treatment. Currently, there is growing interest 
in herbal remedies due to the side effects 
associated with the therapeutic agents (oral 
hypoglycemic agents and insulin) for the 
treatment of diabetes mellitus (Holman and 
Turner, 1991; Kameswara Rao et al., 1997). 
Spices and some herbs are sources of many 
effective antioxidants. Herbal products can 
improve glucose metabolism in diabetic 
individuals not only by having hypoglycemic 
effect, but also by improving lipid 
metabolism, antioxidant status, and capillary 
function (Broadhurst., 1997). Most of the 
cinnamon extracts are safe and having little 
side effects, it is also possesses anti-diabetic 
property (Broadhurst et al., 2000). Cinnamon 
has many pharmacological properties, such as 
antioxidants activity, antibacterial effects, 
natural insulin sensitizer (Lopez et al., 2005), 
and bioactive product that improve glucose 
and insulin metabolism (  Khan et al., 1990; 
Broadhurst., et al 2000) and it is useful for 
treatment of type2 diabetetic patients (Khan et 
al., 1990). Several in vitro and in vivo studies 
have shown cinnamon’s effect on insulin 
signal transduction (Karalee et al., 2001;  Lee 
et al., 2003; Qin et al., 2003; Qin et al., 2004;  
Imparl-Radosevich et al., 1998).. Cinnamon 
lowered blood glucose, total cholesterol, and 
triglyceride levels in diabetic mice (Kim et al., 
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2006). Administered of  1, 3 and 6 doses of 
cinnamon powder (Cinnamomum cassia) for 
over 40 days, were equally effective on 
reducing mean fasting serum glucose, 
triglyceride, LDL cholesterol, and total 
cholesterol levels (Khan et al., 2003). Other 
study evaluated the effects of 1 g cinnamon 
daily for 3 months in diabetic populations and 
no significant changes was observed in levels 
of fasting glucose, total cholesterol, LDL 
cholesterol and HDL cholesterol as well as 
triglycerides, glycosylated hemoglobin and 
insulin (Blevinsn et al., 2007). The aim of this 
study was to evaluate the effect of 
supplementation of cinnamon powder on 
fasting blood glucose levels and lipid profiles 
among type2 diabetic patients. 
 
MATERIALS AND METHODS 
   This double blind clinical trial study was 
conducted in Endocrinology and Diabetes 
Clinic of Tabriz University of Medical 
Sciences, in Iran in 2010. The study was 
approved by Medical Ethical Committee of 
the Tabriz University and also recorded by the 
identification code of IRCT138811133253N1 
in clinical trials registry of Iran. 80 subjects 
were selected based on entry and exit criteria 
of study and medical records. Inclusion 
criteria were: 1) type 2 diabetic individuals 
suffering over 4 years, 2) fasting blood 
glucose range of 160-400 mg/dl, and 3) age of 
patients between 40-60 years old. Exclusion 
criteria were 1) patients with kidney, liver, 
parathyroid, and gastrointestinal diseases, 2) 
patients of pregnancy and breastfeeding, using 
insulin therapy and glycosylated hemoglobin 
less than 7 mg/dl. After an interview, 60 
people declared consent to participate in the 
study. The selected individuals were randomly 
assigned into two groups; study and control 
groups (30 in each group) and followed for 60 
days. The treatment was performed for 8 
weeks. All participants were allowed to take 
their routine diet, physical activity levels and 
usual diabetic medicine until the end of the 
study. This study did not suggest any changes 
in subject's medical care, diet, or exercise. The 
individuals were told to take 3 capsules, each 
containing (500mg) 1.5g of whole cinnamon 
powder, immediately after meals (breakfast, 
lunch and dinner) for 8 weeks. Control group 
intake of placebo. Anthropometric 
parameters including height, weight and 
body mass index (BMI) at the beginning 
and end of the study were measured. BMI 
was calculated using the data recorded for 
height and weight. Venous blood samples 
were taken for measurement of fasting 
blood glucose levels, lipid profiles, 
including triglycerides, total cholesterol, 
HDL and LDL cholesterol at beginning 
and the end of 8 weeks. Fasting blood 
glucose levels and lipid profiles were 
measured two times once at baseline before 
cinnamon intake and the second measured 
after cinnamon intake for 60 days. 
Triglycerides and total cholesterol were 
measure using enzymatic kits (BioSystems 
Spain), and HDL and LDL cholesterol 
were measured using photometric method 
test and devices autoanalyzer Pars (Hitachi 
911, Japan). All data as mean ± SD were 
presented. Paired sample t-test and 
Independent sample t-test were used for 
data analysis. Statistically significant level 
for all tests P<0/05 was considered.  
 
RESULTS 
      Of 80 individuals with type 2 diabetes who 
visited the research center, 20 were excluded 
(18 had various illnesses and 2 due to lack of 
cooperation). The remaining 60 were 
randomized. In the starting of study, there 
were no significant differences of BMI and 
other biochemical factors between the 
cinnamon and control groups. The mean of 
age in cinnamon group and placebo group 
was   59.1±12.1 and 54.6 ±13.1 years, 
respectively. 50% of the participants were 
male and 50% comprised women. There 
were no significant weight, BMI and HDL 
between two groups after intervention. Fasting 
blood glucose levels and lipid profiles 
including total cholesterol, cholesterol LDL 
and triglyceride levels in cinnamon group 
were decreased in compared to control group, 
significantly (p<0.05) (table 1). There were 
no significant changes in BMI, weight and 
HDL in the subjects after consuming of 
cinnamon and placebo (table 1). The mean 
of fasting glucose levels, total cholesterol, 
cholesterol LDL and triglyceride levels 
declined at the end of 8 weeks in comparison 
of the beginning day before cinnamon intake, 
significantly (p<0.05) (table 2). We observed 
no significant changes in fasting blood glucose 
levels and lipid profiles after consumption of 
placebo in control group (table 3).
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Table1. The comparison of anthropometric measurements and biochemical factors in two groups after intervention 
Variables Cinnamon group Control group P value 
Mean ± SD Mean ± SD  
Weight(kg) 78 ± 18 77 ± 8 > o.5 
BMI(kg/m
2
) 28 ± 4 29 ± 7 > o.5 
Fasting blood glucose  
(mg/dl) 
141.1 ± 10 172.6 ± 11 < 0.5* 
total cholesterol (mg/dl) 136.7 ± 6.5 184 ± 9.5 < 0.5* 
triglyceride levels (mg/dl) 122.8 ± 11.5 175.4 ± 16.4 < 0.5* 
LDL (mg/dl) 89 ± 5.6 105.6 ± 7.1 < 0.5* 
HDL (mg/dl) 43.1 ± 1.3 46.5 ± 1 > o.5 
  Data are mean ± Standard deviation.         
*Different is significant at the 0.05 level 
 
Table2. The comparison of anthropometric measurements and biochemical factors in baseline and after intervention in 
cinnamon group 
Variables Baseline End 8 weeks P value 
Weight(kg) 77 ± 17 78 ± 8 > 0.05 
BMI(kg/m
2
) 29 ± 3 28 ± 4 > 0.05 
Fasting blood glucose  (mg/dl) 169 ± 12 141.1 ± 10 < 0.05 
total cholesterol (mg/dl) 175.3 ± 8.3 136.7 ± 6.5 < 0.05 
triglyceride levels (mg/dl) 165.5 ± 15.5 122.8 ± 11.5 < 0.05 
LDL (mg/dl) 100.5 ± 6.6 89 ± 5.6 < 0.05 
HDL (mg/dl) 42.2 ± 1.7 43.1 ± 1.3 > 0.05 
Data are means ± Standard deviation 
*Different is significant at the 0.05 level 
 
Table 3. The comparison of anthropometric measurements and biochemical factors in baseline and end 8 weeks in 
 control group 
  Variables Baseline End 8 weeks P value 
Weight(kg) 78 ± 8 77 ± 8 NS 
BMI(kg/m
2
) 29 ± 7 29 ± 7 NS 
Fasting blood glucose  (mg/dl) 174 ± 12.3 172.6 ± 11 NS 
total cholesterol (mg/dl) 181.6 ± 8.3 184 ± 9.5 NS 
triglyceride levels (mg/dl) 172.3 ± 16.1 175.4 ± 16.4 NS 
LDL (mg/dl) 104 ± 7 105.6 ± 7.1 NS 
HDL (mg/dl) 46 ± 1.5 46.5 ± 1 NS 
Data are means ± Standard deviation 
NS= non significant  
 
DISCUSSION 
   Our study indicates that 1.5g of cinnamon 
supplementation for 8 weeks improve fasting 
blood glucose levels and lipid profiles in type2 
diabetic patients.  A number of plant species 
have been described as hypoglycaemic, and 
they are beneficial in treating elevated fasting 
blood sugar [8]. In vitro and in vivo data were 
showed cinnamon have supporting the role of 
on glycemic control [19]. In study of Khan et 
al. was showed that cinnamon consumption in 
doses of 1, 3, or 6 g daily for a period of 40 
days led to a major reduction in fasting blood 
glucose, triglyceride, LDL, and total 
cholesterol levels [17]. We found significant 
reduction fasting blood glucose, triglyceride, 
LDL, and total cholesterol levels, which 
seemed small amounts of cinnamon likely 
represent a safe and control risk factors of 
diabetic patients. Reduction of biochemical 
parameters after cinnamon intake might be 
related to an unidentified factor present in 
cinnamon that potentiates the action of insulin 
in carbohydrate metabolism. Polyphenolic 
polymers found in cinnamon may function as 
antioxidants, potentiate insulin action, and 
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may be useful in the control of glucose 
intolerance and diabetes [20]. In study of 
Broadhurst, et al recognized the presence of 
this factor in cinnamon. This unidentified 
factor improved the activity of insulin 3 fold 
in glucose metabolism in rat [8]. Other study 
reported methylehydroxy chalcone polymers 
(MHCP) as the unidentified factor in 
cinnamon. MHCP make fat cells more reactive 
to insulin by activating the enzyme that causes 
insulin to join to cells (insulin-receptorkinase) 
and inhibiting the enzyme that blocks this 
progression (insulin-receptor-phosphatase) 
leading to maximal phosphorylation of the 
insulin receptor, which is related to increased 
insulin sensitivity[19]. Ziegenfuss et al    
indicated consumption of water-soluble 
cinnamon extract that was equivalent to 3 
g/day of whole cinnamon powder for 12-
weeks leads to significant improvements in 
fasting blood sugar [21]. This study is 
different from the trial of Vanschoonbeek et 
al. They reported no effect of 1.5 g/d for 6 
weeks cinnamon powder on indices of 
glycemic control in 25 postmenopausal 
women from the Netherlands [22]. This study 
showed that cinnamon supplementation is 
effective in reduction fasting blood glucose 
levels and some lipid profiles among type2 
diabetic patients. This research demonstrate 
positive effect of cinnamon supplementation 
on decreasing fasting blood glucose levels and 
modulate the blood lipid profiles, therefore, 
we conclude that the proposed health benefits 
of cinnamon supplementation in type2 diabetic 
patients could improve some of biochemical 
factor levels. Small amounts of cinnamon 
possible represent a safe and effective means 
to reduce the risk factors associated with type2 
diabetic patients. If diabetes patients apply 
cinnamon in their food preparations regularly, 
they may keep their fasting blood sugar levels 
and lipid profiles near to normal levels. 
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